Leukemias: Related News

On Our Blog

Fibrous extensions of a nerve cell (red) and an oligodendrocyte (green) growing on top of the nerve cell
Can Stem Cells Be Taught to Repair a Radiation-Damaged Brain?

In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.

February 5, 2015
Stained pathology slides of a patient’s tumor (right) and of an organoid made from that tumor (left).
Five Fascinating Approaches to Cancer Science

From tropical plants and 3-D snapshots of worms to tiny particles that light up tumors, here’s a glimpse at some of the fascinating work MSK researchers pursued in 2014 as part of our quest to advance cancer science.

December 30, 2014
Pictured: Eytan Stein
Can Cells Be Turned from Cancerous to Normal?

An experimental drug for blood cancers with certain genetic mutations is showing promise in early-stage trials.

December 11, 2014
DNA wrapped around histones
What Is Epigenetics?

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.

October 14, 2014
Solutions for Chemotherapy-Related Nausea and Vomiting

With quick action and the help of the right medicine at the right time, chemotherapy-induced nausea and vomiting can often be prevented, says MSK Nurse Leader Corey Russell.

September 29, 2014
Transplant Patients Walk Hospital Halls to Support Bone Marrow Donation

Transplant patients at Memorial Sloan Kettering gave support to bone marrow donation efforts with their own “walk” inside the hospital.

September 25, 2014
Compound from Tropical Plant Targets Key Cancer-Causing Genes

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.

July 28, 2014
Memorial Sloan Kettering Transforms Cancer Research and Care Delivery

Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.

July 11, 2014
pictured: Martin S. Tallman
At Work: Leukemia Specialist Martin Tallman

Leukemia Specialist Martin Tallman discusses how research has led to improvements in the treatment of leukemia and what challenges remain.

May 19, 2014
Pictured: José Baselga
Memorial Sloan Kettering Featured Prominently at Major Cancer Research Meeting

Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research.

April 10, 2014
Pictured: Susan Prockop & Lucas T.
Wiping Out Epstein-Barr Virus Preserves Transplant Success

Memorial Sloan Kettering physician-scientists have prevented a dangerous complication of stem cell transplantation using immune cells donated from a third party.

March 6, 2014
Pictured: Sergio Giralt
Memorial Sloan Kettering’s Expertise Stands Out at Transplant Meeting

Memorial Sloan Kettering’s leadership in blood and marrow stem cell transplantation is on full display at the 2014 BMT Tandem Meeting.

February 26, 2014
Pictured: Ellin Berman
Meet Leukemia Expert Ellin Berman

Oncologist and hematologist Ellin Berman describes how a team of experts provides a variety of therapeutic options to patients with leukemia, from standard of care treatments to new therapies available in clinical trials.

January 3, 2014
Pictured: T cells
Cancer Immunotherapy Named Science Magazine “Breakthrough of the Year”

Memorial Sloan Kettering researchers have played a major role in cancer immunotherapy research, named “Breakthrough of the Year” by Science magazine.

December 23, 2013
Pictured: Ross Levine
New Diagnostic Test for Blood Cancers Will Help Doctors Tailor Treatments

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

December 9, 2013
Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
New Biotech Startup Will Pit the Immune System Against Cancer

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.

December 6, 2013
Pictured: Farid Boulad
New Information about Treatment for Pediatric Blood Disorders at Memorial Sloan Kettering

Memorial Sloan Kettering specialists provide state-of-the-art care for a range of pediatric blood disorders.

November 14, 2013
Pictured: Sergio Giralt & Robin Roberts
Robin Roberts Celebrates with Fellow Stem Cell Transplant Recipients

Robin Roberts celebrated with more than 200 fellow stem cell transplant patients at Memorial Sloan Kettering’s annual Stem Cell Transplant Survivors Celebration.

October 17, 2013
Pictured: Andromachi Scaradavou
How Do I Decide Whether I Should Bank Cord Blood from My Newborn?

In this “Ask the Expert” feature, pediatric hematologist Andromachi Scaradavou discusses options for expectant parents who are considering banking a newborn’s cord blood.

July 24, 2013
Pictured: Dan Douer
Meet Leukemia Expert Dan Douer

Dr. Douer, leader of the research program in acute lymphoblastic leukemia, talks about how patients are treated by a caring team that includes physicians, nurses, social workers, and support staff.

April 10, 2013
Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.

March 20, 2013
Pictured: Stephen Chung
Meet Leukemia Expert Stephen Chung

Medical oncologist Dr. Chung specializes in working with patients who have leukemia and bone marrow failure syndromes, from diagnosis through treatment and general medical care.

March 18, 2013
Pictured: ESK1 Monoclonal Antibody
New Molecule Targets Proteins Inside Cancer Cells

Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

March 13, 2013
Pictured: Martin Tallman
Meet Leukemia Expert Martin Tallman

Chief of the Leukemia Service Dr. Tallman discusses how experts collaborate to deliver the most-promising therapies, and how he cares for patients as if they were members of his own family.

February 27, 2013
Cancer Genomics: Improved Understanding of Molecular Changes in Tumors Produces More-Specialized Treatments

With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.

September 21, 2012
Pictured: Ross Levine
Researchers Discover Why Some Leukemia Drugs Are Not Sufficiently Effective

Memorial Sloan Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.

September 6, 2012
Pictured: Natural Killer Cells & Cancer Cell
Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia

In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.

September 4, 2012
Pictured: Sergio Giralt
Memorial Sloan Kettering’s One-Year Survival Rate after Allogeneic Bone Marrow Transplant Exceeds Expectations

Adult Bone Marrow Transplantation Service Chief Sergio Giralt explains recent advances that are enabling more patients to survive the most difficult period after receiving a transplant.

March 26, 2012
Pictured: Ross Levine
Genetic Profiling Could Help Doctors Make More-Accurate Leukemia Prognoses

Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).

March 15, 2012
Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
Cell-Based Therapies Show Promise

Years of innovative research, technology development, and facility expansion at Memorial Sloan Kettering have led to several new experimental treatments for people with cancer.

December 28, 2011
Pictured: Hans-Guido Wendel
Genetic Causes of Blood Cancers Explored

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

December 20, 2011
Pictured: Ronald DeMatteo
Researchers Discover Imatinib’s Effect Is Due Partly to Immune System

A surprising discovery has been made about how the cancer drug imatinib (Gleevec ®) works in treating blood cancers and gastrointestinal stromal tumors.

December 9, 2011
Memorial Sloan Kettering Researchers Discover How Gene Mutation Contributes to Leukemia

A study led by researchers at Memorial Sloan Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells.

October 21, 2011
Monoclonal Antibody Drugs for Cancer Treatment

Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.

December 1, 2008

Related Media Coverage

Leukemia Therapy Shows Promise

Medical oncologist Eytan Stein discusses the novel drug AG-221. The drug generated durable remissions in patients with acute myeloid leukemia (AML) by targeting a mutation of the IDH2 gene in a small, first-in-man study that represents a new, chemotherapy-free approach for attacking the malignancy.

December 7, 2014
Understanding Blood Cancers

Physician-scientist Marcel R.M. van den Brink discusses blood cancers in U.S. News & World Report.

November 13, 2014
T-Cell Therapy Puts Leukemia Patients in Extended Remission

Cell researcher Michel Sadelain discusses experimental leukemia treatment therapies in The New York Times.

October 16, 2014
Agios Leukemia Drug Shows Promise in Tiny, Early Study

Medical oncologist Eytan Stein was interviewed about a clinical trial he is leading to test a new leukemia drug.

April 6, 2014
Revving Up Immune System Helps Fight Leukemia

Medical oncologist Renier Brentjens spoke about a study he and cell researcher Michel Sadelain are conducting that uses a cell-based immune therapy to treat an aggressive form of leukemia.

February 19, 2014
Your Body Can Kill Cancer. It Just Needs Better Instructions.

Cell researcher Michel Sadelain spoke about a new technique that re-programs peoples’ immune systems to fight cancer.

February 1, 2014
After Brief Halt, FDA Allows Sales of Drug for Cancer to Resume

Medical oncologist Michael Mauro commented on an FDA decision to resume sales of a leukemia drug that has been keeping patients alive but also comes with serious side effects.

December 21, 2013
Killing Cancer like the Common Cold

Physician-scientist Renier Brentjens commented on promising results of three separate studies of immunotherapies for leukemia.

December 9, 2013
ASH 2013 Preview: CAR Modified T Cells, Novel Assays, and Ibrutinib

Hematologic Oncology Division Head Marcel van den Brink comments on abstracts being presented by Memorial Sloan Kettering physicians at the 2013 American Society of Hematology Annual Meeting and Exposition.

December 4, 2013
Doctors Fear Losing Leukemia Drug Deemed Risky

Medical oncologist Michael Mauro commented on an FDA decision to ban the sale of a leukemia drug that has been keeping patients alive but also comes with serious side effects.

November 2, 2013
Pictured: Ross Levine
Gene Mutation Contributes To Leukemia By Enhancing Function Of Blood Stem Cells

Memorial Sloan Kettering researchers helped to identify a key insight into what first goes wrong in the development of many leukemias.

June 30, 2011
Martin S. Tallman Named Chief of the Leukemia Service in the Department of Medicine

Martin S. Tallman, MD, has been appointed Chief of the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College.

May 11, 2010
Novel Mechanism Found That May Boost Impaired Function of Leukemia Protein

A new study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia.

February 29, 2008
Protein Regulates Quiescent Blood Stem Cells that Are Linked to Enhanced Recovery from Radiation and Chemotherapy

Scientists have uncovered new information about what orchestrates the complex balance between blood stem cells and mature blood cells, a relationship that is often disrupted in leukemia. The results will lead to a better understanding of the behavior of leukemic cells and may have vital clinical applications for patients recovering from chemotherapy, radiation therapy, or bone marrow transplantation.

March 13, 2006